Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CAV2 |
| Upstream (Parents) |
|---|
| (<<) TPST1 → CAV2 |
| (<<) MPDZ → CAV2 |
| (<<) FERMT2 → CAV2 |
| (<<) LDB2 → CAV2 |
| Downstream (Children) |
|---|
| CAV2 → HHLA1 (>>) |
| CAV2 → CRTC1 (>>) |
| CAV2 → FYN (>>) |
| CAV2 → ALCAM (>>) |
| CAV2 → STAG3L1 (>>) |
| CAV2 → LRRTM4 (>>) |
| CAV2 → GTPBP10 (>>) |
| CAV2 → LCMT2 (>>) |
| CAV2 → GDF9 (>>) |
| CAV2 → PRG3 (>>) |
| CAV2 → PSD3 (>>) |
| CAV2 → OR10J1 (>>) |
| CAV2 → FLRT3 (>>) |
| CAV2 → SEMA4F (>>) |
